PharVision Advisers’s Roblox RBLX Stock Holding History

PharVision Advisers’s Portfolio RBLX Stock Details RBLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,714	Closed	-$220K	–	526
2025 Q4	$220K	Buy	2,714 +1,139	+72%	+$121K	0.11%	482
2025 Q3	$218K	Buy	+1,575	New	+$196K	0.12%	437

Other funds holding RBLX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

IEQ Capital Foster City, California $21.5B AUM 75.26% 1-Year Est. Return

PharVision Advisers's RBLX Position: Q1 2026 in Review

PharVision Advisers sold out of Roblox (RBLX) in Q1 2026, closing a stake of 2,714 shares — an estimated $220K sold.

PharVision Advisers first reported a position in RBLX in Q3 2025 and held it in 2 quarters. The position peaked at $220K in Q4 2025. 831 funds tracked by Wall St. Rank hold RBLX as of Q1 2026.

PharVision Advisers reported no remaining Roblox position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 2,714 Roblox shares in Q1 2026, an estimated $220K.
PharVision Advisers first reported a position in Roblox in Q3 2025 and held it in 2 quarters.
PharVision Advisers's Roblox position peaked at $220K in Q4 2025.
831 funds tracked by Wall St. Rank held Roblox as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.